Although several SIK inhibitors have already been investigated [7,10,13,14], all these reagents exhibit a common problem: the lack of specificity and significant off-target activity limiting their use as mechanistic tools for studying the role of SIK kinases in cancer and other diseases [15]. This evidence concerns the gene SIK1 and cancer.